BIOTECHNOLOGY VALUE FUND L P 13D and 13G filings for Therapeutics Acquisition Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 7:58 pm Sale |
2020-12-31 | 13G | Therapeutics Acquisition Corp. RACA |
BIOTECHNOLOGY VALUE FUND L P | 954,996 6.800% |
-45,004 (-4.50%) |
Filing |
| 2020-07-20 4:35 pm Purchase |
2020-07-08 | 13G | Therapeutics Acquisition Corp. RACA |
BIOTECHNOLOGY VALUE FUND L P | 1,000,000 5.900% |
1,000,000 (New Position) |
Filing |